📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
3 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
NEUTRAL
TOTAL VIEWS
12
ADPT Latest News & AI Sentiment Analysis
3 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 4 ARTICLES
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
ADPT announced its Q2 2026 earnings release date for July 29, 2026 after-hours, with a management webcast scheduled for 4:30 p.m. ET....
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
Adaptive Biotechnologies (ADPT) announced a structural separation of its two primary business units—Minimal Residual Disease (MRD)...
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
Adaptive Biotechnologies (ADPT) announced a $250 million convertible senior notes offering due 2031, targeting qualified institutional...
What Does an Adaptive Biotech Insider's Sale of Nearly 40,000 Shares Mean for Investors?
ADPT's reported insider sale of ~40,000 shares represents a standard portfolio management action rather than a directional signal on...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice